AGM Orthopaedics
Ratchet tourniquet for one-handed hemorrhage control.
Latest event found: 6 Sep 2026 · about 1 month ago
Vitality Radar
Pillar Analysis
Strategic Assessment
Strategic Vector
AGM Orthopaedics is pursuing a focused dual-use medical-device strategy centered on scaling the TRUST tactical tourniquet and building distributor and NATO/EU market access. Public activity indicates increasing international visibility in 2026, but limited evidence of contracts, revenue growth, or organizational expansion.
Efficiency Ratio
The company appears resource-efficient for a 1-10-person manufacturer, converting a compact clinician-led team into a CE-certified, EUDAMED-registered and NATO-codified product platform, although publicly verifiable commercial output remains limited.
Evidence Signals
AGM Orthopaedics was listed as a participating company at the Latvian Dual Use Export Forum 2026, presenting tactical tourniquets for bleeding control.
AGM Orthopaedics exhibited the TRUST Tactical Rapid Use Tourniquet at Eurosatory 2026 in the FSDI Latvia National Stand, Hall 4, Stand E108.
Background · older than 12 months
The company states that development of the TRUST Tactical Rapid Use Tourniquet began in response to battlefield requirements and limitations of legacy windlass tourniquets.